Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis
Clinical trial NCT03069144 · COMPLETED
Trial details
- NCT number
- NCT03069144
- Sponsor
- Haus Bioceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-06
- Primary completion
- 2012-04-11
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.